{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:29:20Z","timestamp":1778254160149,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11095-015-1677-3","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T21:02:46Z","timestamp":1437512566000},"page":"3137-3148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis"],"prefix":"10.1007","volume":"32","author":[{"given":"Rekha","family":"Devi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Hurkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"key":"1677_CR1","first-page":"1","volume":"12","author":"J Soteloand","year":"2002","unstructured":"Soteloand J, Del Brutto OH. Review of neurocysticercosis. Neurosurg Focus. 2002;12:1\u20137.","journal-title":"Neurosurg Focus"},{"key":"1677_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","volume":"72","author":"HH Garcia","year":"2011","unstructured":"Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol. 2011;72:77\u201384.","journal-title":"Br J Clin Pharmacol"},{"key":"1677_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/1357-4310(96)88720-X","volume":"2","author":"NJ Abbottand","year":"1996","unstructured":"Abbottand NJ, Romero IA. Transporting therapeutics across the blood\u2013brain barrier. Mol Med Today. 1996;2:106\u201313.","journal-title":"Mol Med Today"},{"key":"1677_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","volume":"6","author":"W L\u00f6scherand","year":"2005","unstructured":"L\u00f6scherand W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci. 2005;6:591\u2013602.","journal-title":"Nat Rev Neurosci"},{"key":"1677_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1602\/neurorx.2.1.54","volume":"2","author":"A Tsuji","year":"2005","unstructured":"Tsuji A. Small molecular drug transfer across the blood\u2013brain barrier via carrier-mediated transport systems. NeuroRx. 2005;2:54\u201362.","journal-title":"NeuroRx"},{"key":"1677_CR6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/jps.21895","volume":"99","author":"MH Kim","year":"2010","unstructured":"Kim MH, Maeng HJ, Yu KH, Lee KR, Tsuruo T, Kim DD, et al. Evidence of carrier\u2010mediated transport in the penetration of donepezil into the rat brain. J Pharm Sci. 2010;99:1548\u201366.","journal-title":"J Pharm Sci"},{"key":"1677_CR7","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pntd.0000194","volume":"2","author":"DK Matthaiou","year":"2008","unstructured":"Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis. 2008;2:e194.","journal-title":"PLoS Negl Trop Dis"},{"key":"1677_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0022-510X(95)00181-Z","volume":"133","author":"I Cruz","year":"1995","unstructured":"Cruz I, Cruz M, Carrasco F, Horton J. Neurocysticercosis: optimal dose treatment with albendazole. J Neurol Sci. 1995;133:152\u20134.","journal-title":"J Neurol Sci"},{"key":"1677_CR9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","volume":"79","author":"A Carpio","year":"2008","unstructured":"Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008;79:1050\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1677_CR10","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s11095-008-9615-2","volume":"25","author":"N Chattopadhyay","year":"2008","unstructured":"Chattopadhyay N, Zastre J, Wong H-L, Wu XY, Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res. 2008;25:2262\u201371.","journal-title":"Pharm Res"},{"key":"1677_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scherand","year":"2005","unstructured":"L\u00f6scherand W, Potschka H. Blood\u2013brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx. 2005;2:86\u201398.","journal-title":"NeuroRx"},{"key":"1677_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","volume":"87","author":"I Brasnjevic","year":"2009","unstructured":"Brasnjevic I, Steinbusch HW, Schmitz C, Martinez-Martinez P. Delivery of peptide and protein drugs over the blood\u2013brain barrier. Prog Neurobiol. 2009;87:212\u201351.","journal-title":"Prog Neurobiol"},{"key":"1677_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-2022-6","volume":"15","author":"P Kharya","year":"2013","unstructured":"Kharya P, Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P, et al. Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting. J Nanoparticle Res. 2013;15:1\u201312.","journal-title":"J Nanoparticle Res"},{"key":"1677_CR14","doi-asserted-by":"crossref","unstructured":"Rai A, Jain A, Jain A, Jain A, Pandey V, Chashoo G, et al. Targeted SLNs for management of HIV-1 associated dementia. Drug Dev Ind Pharm. 2014;1\u20137.","DOI":"10.3109\/03639045.2014.948453"},{"key":"1677_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z. Molecular biology of the blood\u2013brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS. 2011;8:1\u201325.","journal-title":"Fluids Barriers CNS"},{"key":"1677_CR16","doi-asserted-by":"crossref","unstructured":"Mamta Bishnoi AJ, Pooja Hurkat, Jain SK. Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis. J Drug Target. 2014;1\u20138.","DOI":"10.3109\/1061186X.2014.928714"},{"key":"1677_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH Mu\u00c8ller","year":"2000","unstructured":"Mu\u00c8ller RH, Ma\u00c8der K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161\u201377.","journal-title":"Eur J Pharm Biopharm"},{"key":"1677_CR18","unstructured":"M\u00fcller R, Hildebrand G, Nitzsche R, Paulke B-R. Zetapotential und Partikelladung in der Laborpraxis. PAPERBACK APV. 1996;37."},{"key":"1677_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2012.06.002","volume":"163","author":"SB Lim","year":"2012","unstructured":"Lim SB, Banerjee A, \u00d6ny\u00fcksel H. Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release. 2012;163:34\u201345.","journal-title":"J Control Release"},{"key":"1677_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","volume":"127","author":"IP Kaur","year":"2008","unstructured":"Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J Control Release. 2008;127:97\u2013109.","journal-title":"J Control Release"},{"key":"1677_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","volume":"59","author":"P Blasi","year":"2007","unstructured":"Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"1677_CR22","first-page":"203","volume-title":"Drug nanocarriers","author":"A Jain","year":"2014","unstructured":"Jain A, Jain SK. Brain Targeting Using Surface Functionalized Nanocarriers in human solid tumors. In: Singh B, Jain NK, Katare OP, editors. Drug nanocarriers. Houston: Series Nanobiomedicine Studium Press; 2014. p. 203\u201355."},{"key":"1677_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/fon.09.145","volume":"6","author":"KM Kennedyand","year":"2010","unstructured":"Kennedyand KM, Dewhirst MW. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. Future Oncol. 2010;6:127\u201348.","journal-title":"Future Oncol"},{"key":"1677_CR24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(02)00130-3","volume":"55","author":"M Schubertand","year":"2003","unstructured":"Schubertand M, M\u00fcller-Goymann C. Solvent injection as a new approach for manufacturing lipid nanoparticles\u2013evaluation of the method and process parameters. Eur J Pharm Biopharm. 2003;55:125\u201331.","journal-title":"Eur J Pharm Biopharm"},{"key":"1677_CR25","doi-asserted-by":"crossref","unstructured":"Kocienski PJ. Protecting groups. Thieme. 2005.","DOI":"10.1055\/b-003-108603"},{"key":"1677_CR26","doi-asserted-by":"crossref","unstructured":"Greeneand TW, Wuts PG. Protection for the Hydroxyl Group, Including 1, 2\u2010and 1, 3\u2010Diols. 3rd ed. Protective Groups in Organic Synthesis; 1999 pp. 17\u2013245.","DOI":"10.1002\/0471220574.ch2"},{"key":"1677_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","volume":"70","author":"KS Soppimath","year":"2001","unstructured":"Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1\u201320.","journal-title":"J Control Release"},{"key":"1677_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/243831","volume":"15","author":"A Jain","year":"2013","unstructured":"Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Jain SK. Dual drug delivery using \u201csmart\u201d liposomes for triggered release of anticancer agents. J Nanoparticle Res. 2013;15:1\u201312.","journal-title":"J Nanoparticle Res"},{"key":"1677_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2007.11.040","volume":"353","author":"T Truong Cong","year":"2008","unstructured":"Truong Cong T, Faivre V, Nguyen TT, Heras H, Pirot F, Walchshofer N, et al. Study on the hydatid cyst membrane: permeation of model molecules and interactions with drug-loaded nanoparticles. Int J Pharm. 2008;353:223\u201332.","journal-title":"Int J Pharm"},{"key":"1677_CR30","doi-asserted-by":"crossref","unstructured":"Souto EB, Fangueiro JF, M\u00fcller RH. Solid Lipid Nanoparticles (SLN\u2122). Fundamentals of pharmaceutical nanoscience, Springer: 2013, pp. 91\u2013116.","DOI":"10.1007\/978-1-4614-9164-4_5"},{"key":"1677_CR31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","volume":"5","author":"R Paliwal","year":"2009","unstructured":"Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine Nanotechnol Biol Med. 2009;5:184\u201391.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"1677_CR32","doi-asserted-by":"crossref","unstructured":"Bishnoi M, Jain A, Hurkat P, Jain SK. Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis. J Drug Target. 2014;1\u20138.","DOI":"10.3109\/1061186X.2014.928714"},{"key":"1677_CR33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","volume":"95","author":"V Venkateswarluand","year":"2004","unstructured":"Venkateswarluand V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004;95:627\u201338.","journal-title":"J Control Release"},{"key":"1677_CR34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/10611860600888850","volume":"14","author":"K Manjunathand","year":"2006","unstructured":"Manjunathand K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. J Drug Target. 2006;14:632\u201345.","journal-title":"J Drug Target"},{"key":"1677_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10611860500071292","volume":"13","author":"TM G\u00f6ppertand","year":"2005","unstructured":"G\u00f6ppertand TM, M\u00fcller RH. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target. 2005;13:179\u201387.","journal-title":"J Drug Target"},{"key":"1677_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1007518525161","volume":"17","author":"Y Kido","year":"2000","unstructured":"Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood\u2013brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res. 2000;17:55\u201362.","journal-title":"Pharm Res"},{"key":"1677_CR37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1006\/bbrc.1995.2312","volume":"214","author":"I Tamai","year":"1995","unstructured":"Tamai I, Takanaga H, Ogihara T, Higashida H, Maeda H, Sai Y, et al. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem Biophys Res Commun. 1995;214:482\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1677_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jnr.20294","volume":"79","author":"L Hertzand","year":"2005","unstructured":"Hertzand L, Dienel GA. Lactate transport and transporters: general principles and functional roles in brain cells. J Neurosci Res. 2005;79:11\u20138.","journal-title":"J Neurosci Res"},{"key":"1677_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2011.09.039","volume":"421","author":"A Agarwal","year":"2011","unstructured":"Agarwal A, Agrawal H, Tiwari S, Jain S, Agrawal GP. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting. Int J Pharm. 2011;421:189\u2013201.","journal-title":"Int J Pharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-015-1677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-015-1677-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-015-1677-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:35:30Z","timestamp":1717990530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-015-1677-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1677"],"URL":"https:\/\/doi.org\/10.1007\/s11095-015-1677-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]}}}